Bionomics Limited - American De (BNOX) Financials

BNOX Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 27.6 million 6.3 million
June 30, 2023 28.5 million 6.5 million
March 31, 2023 11.0 million 1.4 million
Dec. 31, 2022 38.4 million 5.8 million

BNOX Free Cash Flow and Stock based compensation

No data available :(

BNOX Net Income

No data available :(

BNOX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 11.7 million - -
June 30, 2023 12.1 million - 353994
March 31, 2023 5.6 million - -
Dec. 31, 2022 20.9 million - 418615

BNOX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 5.2 million
June 30, 2023 974.4 million
March 31, 2023 5.9 million
Dec. 31, 2022 5.6 million

BNOX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 3.8 million 1.5 million 35094
June 30, 2023 - - - -
March 31, 2023 106101 3.0 million 1.5 million 36641
Dec. 31, 2022 - 4.9 million 1.9 million -

BNOX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 9573 2.8 million
June 30, 2023 - -
March 31, 2023 173425 3.0 million
Dec. 31, 2022 44895 -

BNOX

Price: $0.25

52 week price:
0.18
1.60

Earnings Per Share: -1.19 USD

P/E Ratio: -0.38

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 1400

Market Capitalization: 6.3 million

Links: